How can the FDA change its view on drug approvals to give patients access to better therapies? Continue Reading »
How can the FDA change its view on drug approvals to give patients access to better therapies? Continue Reading »
Want better blood sugars? Adam takes a step-by-step approach, with very positive results. Continue Reading »
What’s an SGLT-2 inhibitor and how does it work? Includes cool FAQ! Continue Reading »
Kelly on a heated day at the FDA and why a new drug class could bring diabetes patients, doctors, and educators closer to personalized therapy. Continue Reading »
Gary Scheiner shares how to make your blood glucose data work for you. Continue Reading »
In December, Novo Nordisk announced that it will advance FIAsp, an ultra-rapid-acting version of Novolog (insulin... Continue Reading »
Ever wondered if we have it better or worse than other countries? Dr. Dorothee Deiss reveals the state of diabetes care in Germany. Continue Reading »
Gary Scheiner searches for the happy medium between neglecting your diabetes care and being completely overwhelmed. Continue Reading »